BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toy M, Hutton D, Harris AM, Nelson N, Salomon JA, So S. Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States. Clin Infect Dis 2021:ciab405. [PMID: 33956937 DOI: 10.1093/cid/ciab405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng T, Li G, Ning H, Hao L. Antiviral Therapy for Chronic Hepatitis B Infection Improves Outcomes After Total Hip Arthroplasty: A Multicenter Retrospective Study. J Arthroplasty 2023;38:300-6. [PMID: 35963280 DOI: 10.1016/j.arth.2022.08.005] [Reference Citation Analysis]
2 Xiao Y, Hellard ME, Thompson AJ, Seaman C, Howell J, Scott N. The cost-effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030. Med J Aust 2023. [PMID: 36596568 DOI: 10.5694/mja2.51825] [Reference Citation Analysis]
3 Dieterich D, Graham C, Wang S, Kwo P, Lim Y, Liu C, Agarwal K, Sulkowski M. It Is Time for a Simplified Approach to Hepatitis B Elimination. Gastro Hep Advances 2023;2:209-218. [DOI: 10.1016/j.gastha.2022.10.004] [Reference Citation Analysis]
4 Ren W, Wu Z, Liu Y, Qiu Y, Yao J, Ren J. Evaluation of the effect of enhanced immunization in adults: A cross-sectional study in the southeast city of China. Hum Vaccin Immunother 2022;18:2096972. [PMID: 35878394 DOI: 10.1080/21645515.2022.2096972] [Reference Citation Analysis]
5 Hwang JP, Artz AS, Shah P, Symington B, Feld JJ, Hammond SP, Ludwig E, Pai A, Ramsey SD, Schlam I, Suga JM, Wang SH, Somerfield MR. Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer. JCO Oncology Practice 2022;18:636-644. [DOI: 10.1200/op.22.00074] [Reference Citation Analysis]
6 Shamaa O, Mendiratta V, Trudeau S, Gordon SC. Evolving Screening and Vaccination Recommendations for Hepatitis B in the USA. Curr Hepatology Rep 2022;21:37-43. [DOI: 10.1007/s11901-022-00583-3] [Reference Citation Analysis]
7 Chu JN, Nguyen TT, Rivadeneira NA, Hiatt RA, Sarkar U. Exploring factors associated with hepatitis B screening in a multilingual and diverse population. BMC Health Serv Res 2022;22:479. [PMID: 35410249 DOI: 10.1186/s12913-022-07813-w] [Reference Citation Analysis]
8 Cohen C, Moraras K, Jackson M, Kamischke M, Gish RG, Brosgart CL, Toy M, Hutton D, Block TM, Wang S, So S. Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United States. Hepatology 2022;75:1062-3. [PMID: 34951931 DOI: 10.1002/hep.32304] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen VL, Ramrakhiani NS, Nguyen MH. Reply. Hepatology 2022;75:1063-4. [PMID: 34951716 DOI: 10.1002/hep.32303] [Reference Citation Analysis]
10 Sohn E. The global fight against hepatitis B is benefitting some parts of the world more than others. Nature 2022;603:S58-9. [PMID: 35354994 DOI: 10.1038/d41586-022-00818-9] [Reference Citation Analysis]
11 Campbell K. Hepatitis B and the liver cancer endgame. Nature 2022;603:S64-5. [DOI: 10.1038/d41586-022-00821-0] [Reference Citation Analysis]
12 One-time universal HBsAg screening for hepatitis B cost saving in the USA. PharmacoEcon Outcomes News 2021;879:21-21. [DOI: 10.1007/s40274-021-7744-6] [Reference Citation Analysis]